Abbott Collaborates with NIH on Brain Initiative for Advancing Research on Neurological Disorders


  • Abbott to provide its neuromodulation technologies including deep brain stimulation (DBS), spinal cord stimulation (SCS), and dorsal root ganglion (DRG) therapy. NIH to utilize Abbott’s technology for exploring its applications in chronic pain and progressive movement disorders as Parkinson’s disease
  • The focus of the collaboration is to accelerate the application of Abbott’s neurostimulation therapies, exploring new avenues for neurological conditions
  • Abbott’s neuromodulation technologies determine the inner workings of the nervous system, allowing to explore the interaction of the brain with the human body in patients with neurological conditions

Click here to read full press release/ article | Ref: Abbott | Image: The Pharma Letter